Umeå
Sweden
2
2022-05-26
2
2023-10-10
These are the the leading inventors for applications assigned to Lipigon Pharmaceuticals AB:
Lipigon Pharmaceuticals AB based in Umeå, SE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
ANGPTL4 oligonucleotides influencing the regulation of the fatty acid metabolism
#2 | 2022-01-13 ✅ Patent 12,024,708 granted on 2024-07-02ANGPTL4 oligonucleotides influencing the regulation of the fatty acid metabolism
Also check out Lipigon Pharmaceuticals AB's (Umeå, Sweden) applicant profile with 2 patent applications submitted.
605317 ⎘